Abstract Analysis and mapping of national data flows and processes relevant to EFSA's business data collections is a long‐standing EFSA objective, originally launched with EFSA's SIGMA project in 2018‐2019 and further continued with the launch of a focused activity to “Develop, pilot and document a methodology for the data flow mapping and analysis in the European Member States” in 2023. The aim of latter activity is to apply a generic methodology for the analysis of any business data collection at Member State level with the ultimate purpose for countries and EFSA to increase understanding of data flows at national level, where existing challenges rely on and what common solutions could be implemented. This report presents results from the execution of the aforementioned methodology on France for the analysis of national data flows which contribute data to Chemical Contaminants Occurrence business data collection. The report contains information on the steps, participant organisations and actors, tools, systems, formats, structural and content metadata, as well as challenges and “pain points” identified in the country's internal data flows related to the collection of the selected data. The presented information has been generated based on the responses submitted by the participating Member State to a survey developed in the context of the data flow mapping and analysis methodology as well as relevant discussions held in a post‐survey interview with the country. Though the information presented on the current report represents real‐world data, it must be clarified that the survey and the follow‐up interview with the MS, have been both performed during the activity of the Data Flow Mapping methodology.
Kollaros et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: